LATS1
Entrez ID: 9113
Full name: large tumor suppressor kinase 1
External links: HGNC UniprotKB Ensembl RefSeq COSMIC
Family: AGC: NDR: LATS
Chromosomal location: 6q25.1
Substructure location: Gatekeeper: 782 A-loop: 845...857, 905...915 G-loop: [N/A] αC-helix: [N/A]
Please click HERE
for better display.
LATS1
Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulato...
Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function. Plays a role in mammary gland epithelial cells differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668).
View more >>
GO - Biological processes (BP):
cell division, cellular protein localization, cytoplasmic sequestering of protein, G1/S transition of mitotic cell cycle, G2/M transition of mitotic cell cycle, hippo signaling, hormone-mediated signaling pathway, inner cell mass cell fate commitment, inner cell mass cellular morphogenesis, intracel...
cell division, cellular protein localization, cytoplasmic sequestering of protein, G1/S transition of mitotic cell cycle, G2/M transition of mitotic cell cycle, hippo signaling, hormone-mediated signaling pathway, inner cell mass cell fate commitment, inner cell mass cellular morphogenesis, intracellular signal transduction, keratinocyte differentiation, mammary gland epithelial cell differentiation, negative regulation of canonical Wnt signaling pathway, negative regulation of cyclin-dependent protein serine/threonine kinase activity, peptidyl-serine phosphorylation, positive regulation of apoptotic process, positive regulation of peptidyl-serine phosphorylation, protein phosphorylation, regulation of actin filament polymerization, regulation of intracellular estrogen receptor signaling pathway, regulation of organ growth, regulation of protein-containing complex assembly, regulation of ubiquitin-dependent protein catabolic process, sister chromatid segregation
View more >>
GO - Molecular function (MF):
ATP binding, estrogen receptor binding, magnesium ion binding, protein kinase binding, protein serine/threonine kinase activity...
ATP binding, estrogen receptor binding, magnesium ion binding, protein kinase binding, protein serine/threonine kinase activity
View more >>
GO - Cellular component (CC):
microtubule organizing center, spindle pole, cytosol...
microtubule organizing center, spindle pole, cytosol
View more >>
large tumor suppressor kinase 1
Control panel
Show dataset:
Show substructure:
All sites
Gatekeeper
A-loop
G-loop
αC-helix
Gatekeeper
A-loop
G-loop
αC-helix
Filter mutation sites
All sites
Minimum 5 samples
Minimum 10 samples
Minimum 5 samples
Minimum 10 samples
Data table is loading....
Kaplan plot for LATS1 in
Download patient group data (Lower:Upper = 50%:50%)
*NOTE: the Kaplan plots were collected from OncoLnc